Wilkinson Walsh Celebrates Another Outstanding Year of High Stakes Trials and Accolades for the Next Generation of Trial Lawyers

WASHINGTON –Wilkinson Walsh enters its fifth year having cemented its status as the premier trial litigation boutique in the country. 2019 featured three high-stakes, high-pressure trials, in which different partners served as lead trial counsel and eight partners in total had stand-up roles. The firm continued to receive accolades for its successes in delivering results to its clients while deepening its diverse bench of go-to litigators.

Wilkinson Walsh Celebrates Banner Year of High Stakes Trial Wins By Next Generation Of Trial Lawyers

WASHINGTON – Wilkinson Walsh is racing into its fourth year after notching a series of high-profile victories, led by a large and diverse group of partners. In 2018, all of Wilkinson Walsh’s partners participated in trials and case-dispositive hearings, and several other attorneys achieved significant on-their-feet experience, including through pro bono cases. The firm earned repeated recognition for the depth and successes of its bench and added a new crop of talented litigators to its roster. Wilkinson Walsh won three trials in 2018, each of which was first-chaired by a different partner: On April 27, 2018, Wilkinson Walsh, led by Brian Stekloff, Jeremy Barber, and Lori McGill, won a unanimous defense verdict for Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals in Russell v. Janssen Pharmaceuticals, Inc., the second state-court Xarelto bellwether trial in the Pennsylvania Court of Common Pleas. On May 21, 2018, Wilkinson Walsh, led by Kosta Stojilkovic …

Wilkinson Walsh Secures Another Trial Victory for Bayer in Xarelto Trial

Alexandra Walsh, co-founding partner of Wilkinson, Walsh + Eskovitz, Tamarra Matthews Johnson, and Rakesh Kilaru led the defense team to another victory. WASHINGTON – The Wilkinson Walsh trial team, led by Founding Partner Alexandra Walsh and partners Tamarra Matthews Johnson and Rakesh Kilaru, won the third state-court bellwether trial over the blood- thinner Xarelto in the Pennsylvania Court of Common Pleas. This is the third win for Bayer in state court, and the sixth win overall, in the Xarelto litigation. The Plaintiff, Kevin Cooney, alleged that Bayer and Johnson & Johnson subsidiary Janssen Pharmaceuticals were liable for claims that the Xarelto label did not adequately warn or instruct doctors on the risks of bleeding associated with the anticoagulant medicine Xarelto. Walsh and Johnson served as lead trial counsel for Bayer, and Kilaru helped direct the legal strategy. A 12-member jury in Philadelphia returned a defense verdict after less than three …

Wilkinson Walsh Adds Tamarra Matthews Johnson as Partner

Matthews Johnson is latest high-profile addition to top boutique trial firm WASHINGTON – Wilkinson Walsh today announced the addition of Tamarra Matthews Johnson as a partner in its Washington, D.C. office. In just 18 months, Wilkinson Walsh has grown to nearly 40 lawyers, and quickly established itself as the leading boutique trial firm in the country.  Matthews Johnson, an experienced litigator at both the appellate and trial level, joins the firm as partner. Throughout her career, she has tried complex civil and criminal cases, and clerked for Supreme Court Justice Sandra Day O’Connor. Tamarra is the firm’s tenth partner, and seventh former Supreme Court clerk. “I could not be more excited to re-enter private practice as a partner of Wilkinson Walsh,” said Ms. Matthews Johnson. “I’m thrilled to be able to call such an impressive group of trial lawyers my colleagues—and the firm’s innovative approach to trying cases is a …